Top-Rated Stocks NYSE:EVH Evolent Health - EVH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $31.41 +0.81 (+2.65%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$30.90▼$31.5550-Day Range$29.94▼$35.8052-Week Range$21.83▼$39.78Volume619,209 shsAverage Volume970,488 shsMarket Capitalization$3.49 billionP/E RatioN/ADividend YieldN/APrice Target$47.70 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Evolent Health MarketRank™ ForecastAnalyst RatingModerate Buy2.90 Rating ScoreUpside/Downside51.9% Upside$47.70 Price TargetShort InterestHealthy4.66% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.85Based on 6 Articles This WeekInsider TradingSelling Shares$12.49 M Sold Last QuarterProj. Earnings Growth364.29%From $0.14 to $0.65 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.59 out of 5 starsComputer And Technology Sector234th out of 614 stocksManagement Services Industry4th out of 7 stocks 3.5 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Buy. The company's average rating score is 2.90, and is based on 9 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $47.70, Evolent Health has a forecasted upside of 51.9% from its current price of $31.41.Amount of Analyst CoverageEvolent Health has only been the subject of 2 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.66% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Evolent Health has recently decreased by 9.44%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 2.7 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Evolent Health this week, compared to 2 articles on an average week.Search InterestOnly 13 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,488,955.00 in company stock.Percentage Held by InsidersOnly 4.20% of the stock of Evolent Health is held by insiders.Percentage Held by Institutions93.33% of the stock of Evolent Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 364.29% in the coming year, from $0.14 to $0.65 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -157.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -157.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 3.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Evolent Health (NYSE:EVH) StockEvolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.Read More Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EVH Stock News HeadlinesMarch 27, 2023 | finance.yahoo.comInvestors in Evolent Health (NYSE:EVH) have made a massive return of 443% over the past three yearsMarch 22, 2023 | americanbankingnews.comEvolent Health, Inc. (NYSE:EVH) Receives $47.70 Average Price Target from AnalystsMarch 28, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.March 20, 2023 | americanbankingnews.comEvolent Health (NYSE:EVH) Coverage Initiated at StockNews.comFebruary 27, 2023 | bizjournals.comEvolent Health maps out growth plan after laying off hundreds of workersFebruary 24, 2023 | seekingalpha.comEvolent Health, Inc. (EVH) Q4 2022 Earnings Call TranscriptFebruary 24, 2023 | finance.yahoo.comEvolent Health Full Year 2022 Earnings: EPS Misses ExpectationsFebruary 23, 2023 | finance.yahoo.comEvolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth OutlookMarch 28, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.February 22, 2023 | msn.comEvolent Health (EVH) Surpasses Q4 Earnings and Revenue EstimatesFebruary 22, 2023 | msn.comEvolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47MFebruary 22, 2023 | finance.yahoo.comEvolent Health Announces Fourth Quarter and Full Year 2022 ResultsFebruary 9, 2023 | finance.yahoo.comEngageSmart (ESMT) Matches Q4 Earnings EstimatesFebruary 2, 2023 | finance.yahoo.comHere’s Why Evolent Health (EVH) Declined in Q4January 31, 2023 | finance.yahoo.comEvolent Health, Inc. to Release Fourth Quarter Financial Results and Host Conference Call on Wednesday, February 22, 2023January 30, 2023 | markets.businessinsider.comCowen & Co. Reaffirms Their Buy Rating on Evolent Health (EVH)January 30, 2023 | msn.comCowen & Co. Maintains Outperform Rating for Evolent Health: Here's What You Need To KnowJanuary 23, 2023 | finance.yahoo.comEvolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On CapitalJanuary 21, 2023 | forbes.comEvolent HealthJanuary 3, 2023 | finance.yahoo.comIs There Now An Opportunity In Evolent Health, Inc. (NYSE:EVH)?December 13, 2022 | finance.yahoo.comAre Investors Undervaluing Evolent Health, Inc. (NYSE:EVH) By 48%?November 21, 2022 | seekingalpha.comEvolent Health: A Bit Complex, But InterestingNovember 18, 2022 | markets.businessinsider.com5 Analysts Have This to Say About Evolent HealthNovember 18, 2022 | finance.yahoo.comWhy Evolent Health Stock Is Soaring TodayNovember 18, 2022 | finance.yahoo.comCentene agrees to sell benefit-management unit to Evolent Health for $750 millionNovember 18, 2022 | finance.yahoo.comClayton-based Centene to sell a specialty benefit management business for $750M in latest divestureNovember 18, 2022 | finance.yahoo.comCentene Agrees To Divest Magellan Specialty Health To Evolent HealthSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EVH Company Calendar Last Earnings2/22/2023Today3/28/2023Next Earnings (Estimated)5/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Management services Sub-IndustryN/A SectorComputer and Technology Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees5,100Year FoundedN/APrice Target and Rating Average Stock Price Forecast$47.70 High Stock Price Forecast$59.00 Low Stock Price Forecast$32.00 Forecasted Upside/Downside+51.9%Consensus RatingModerate Buy Rating Score (0-4)2.90 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($0.20) Trailing P/E RatioN/A Forward P/E Ratio224.36 P/E GrowthN/ANet Income$-19,160,000.00 Net Margins-1.42% Pretax Margin-4.59% Return on Equity7.50% Return on Assets3.55% Debt Debt-to-Equity Ratio0.48 Current Ratio1.10 Quick Ratio1.10 Sales & Book Value Annual Sales$1.35 billion Price / Sales2.58 Cash Flow$1.52 per share Price / Cash Flow20.71 Book Value$8.60 per share Price / Book3.65Miscellaneous Outstanding Shares111,050,000Free Float106,388,000Market Cap$3.49 billion OptionableOptionable Beta1.56 Key ExecutivesSeth B. BlackleyChief Executive Officer & Non-Independent DirectorDan McCarthyPresidentSteven TutewohlChief Operating OfficerJohn JohnsonChief Financial OfficerJohn TamChief Strategy OfficerKey CompetitorsImpinjNASDAQ:PIBadger MeterNYSE:BMISprout SocialNASDAQ:SPTLumentumNASDAQ:LITEZiff DavisNASDAQ:ZDView All CompetitorsInsiders & InstitutionsMetLife Investment Management LLCSold 1,401 shares on 3/23/2023Ownership: 0.039%Victory Capital Management Inc.Bought 242,088 shares on 3/10/2023Ownership: 1.144%Frank J WilliamsSold 90,356 sharesTotal: $3.11 M ($34.42/share)Seth BlackleySold 73,928 sharesTotal: $2.54 M ($34.42/share)Frank J WilliamsSold 110,000 sharesTotal: $3.85 M ($34.98/share)View All Insider TransactionsView All Institutional Transactions EVH Stock - Frequently Asked Questions Should I buy or sell Evolent Health stock right now? 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" EVH shares. View EVH analyst ratings or view top-rated stocks. What is Evolent Health's stock price forecast for 2023? 10 brokerages have issued 1-year price targets for Evolent Health's shares. Their EVH share price forecasts range from $32.00 to $59.00. On average, they anticipate the company's stock price to reach $47.70 in the next twelve months. This suggests a possible upside of 51.9% from the stock's current price. View analysts price targets for EVH or view top-rated stocks among Wall Street analysts. How have EVH shares performed in 2023? Evolent Health's stock was trading at $28.08 on January 1st, 2023. Since then, EVH shares have increased by 11.9% and is now trading at $31.41. View the best growth stocks for 2023 here. Are investors shorting Evolent Health? Evolent Health saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 5,180,000 shares, a decline of 9.4% from the February 28th total of 5,720,000 shares. Based on an average daily volume of 974,800 shares, the days-to-cover ratio is presently 5.3 days. View Evolent Health's Short Interest. When is Evolent Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023. View our EVH earnings forecast. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) announced its quarterly earnings results on Wednesday, February, 22nd. The technology company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by $0.02. The technology company had revenue of $382.43 million for the quarter, compared to analysts' expectations of $373.68 million. Evolent Health had a positive trailing twelve-month return on equity of 7.50% and a negative net margin of 1.42%. What ETFs hold Evolent Health's stock? ETFs with the largest weight of Evolent Health (NYSE:EVH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Invesco DWA SmallCap Momentum ETF (DWAS), Principal U.S. Small-Cap Multi-Factor ETF (PSC), Fidelity Small-Mid Cap Opportunities ETF (FSMO), VictoryShares US Small Mid Cap Value Momentum ETF (USVM), First Trust Small Cap Growth AlphaDEX Fund (FYC), iShares Russell 2000 Growth ETF (IWO) and JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC). What guidance has Evolent Health issued on next quarter's earnings? Evolent Health issued an update on its first quarter 2023 earnings guidance on Wednesday, February, 22nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $420.00 million-$440.00 million, compared to the consensus revenue estimate of $410.36 million. What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX). When did Evolent Health IPO? (EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. What is Evolent Health's stock symbol? Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH." Who are Evolent Health's major shareholders? Evolent Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Point72 Asset Management L.P. (3.23%), Granahan Investment Management LLC (3.14%), Engaged Capital LLC (2.75%), Dimensional Fund Advisors LP (2.51%), Credit Suisse AG (2.32%) and Fred Alger Management LLC (1.87%). Insiders that own company stock include Cheryl Scott, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Evolent Health's stock price today? One share of EVH stock can currently be purchased for approximately $31.41. How much money does Evolent Health make? Evolent Health (NYSE:EVH) has a market capitalization of $3.49 billion and generates $1.35 billion in revenue each year. The technology company earns $-19,160,000.00 in net income (profit) each year or ($0.20) on an earnings per share basis. How many employees does Evolent Health have? The company employs 5,100 workers across the globe. How can I contact Evolent Health? Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The official website for the company is www.evolenthealth.com. The technology company can be reached via phone at (571) 389-6000, via email at investorrelations@evolenthealth.com, or via fax at 571-389-6001. This page (NYSE:EVH) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.